Anjeli Manam, MD
Associate Scholar
- Internal Medicine Resident, University of Pennsylvania
- United States
- Cancer Screening | Disease Prevention | Immigrant health | Subspecialty care in low resource settings
Languages: English, Spanish (Beginner)
BIO STATEMENT
I am an internal medicine resident in the global health equities track. My interests in global health formed during my gap year, where I studied public health and worked in clinical sites throughout Cape Town, South Africa. During my internship there, I provided vaccination education and administration in underserved areas without access to healthcare. In undergrad, I co-started our university’s GlobeMed chapter, built partnerships with organizations, and led monthly seminars on current events in global health for students. In medical school, I helped launch food delivery, telehealth, and interpreter services for communities heavily impacted by the COVID-19 pandemic. Most recently, I spent time working within the Indian Health Services in Navajo Nation, where I witnessed the barriers to both preventative and subspecialty care, and observed how community-based initiatives can create a meaningful impact. I plan to pursue a career in gastroenterology with a focus on improving access to subspecialty care and advancing health equity within the domains of cancer screening and preventative medicine.
Recent Global Health Projects
I am currently working with Puentes de Salud, a South Philadelphia clinic that provides community health services to a primarily immigrant population. We are working on multiple projects related to preventive care and screening.
The first aims to improve access to colorectal cancer screening through Fecal Immunochemical Testing and subsequent referral to subspeciality care. We are working on a QI project around process mapping to improve access to subspecialty care, and have applied for a grant to aid in costs related to FIT kits.
Our second project is focused on screening those who may be at higher risk for metabolic dysfunction-associated steatotic liver disease. We created an algorithm for providers to follow to identify high-risk patients and provided a pathway to support early intervention and disease management in conjunction with Penn hepatology.
Last Updated: 12 May 2025